Condition
Molecular Diagnosis
Total Trials
4
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Unknown2
Not Yet Recruiting2
Clinical Trials (4)
Showing 4 of 4 trials
NCT07497477Not ApplicableNot Yet Recruiting
A Study of Multilocus Methylation Abnormalities in Subjects With Imprinting Disorders
NCT06782607Not ApplicableNot Yet Recruiting
Clinical Impact of a Multiplex Rapid Diagnostic Pneumonia Panel Testing in Critically-ill Patients with Severe Hospital-acquired Pneumonia, Ventilator-associated Pneumonia and Community-acquired Pneumonia with High Risk of Multidrug Resistant Pathogen
NCT05833412Unknown
Molecular Early Sepsis Identification Study
NCT04453540Unknown
FilmArray and Management of ICU Patients With Pneumonia in the Covid-19 Context
Showing all 4 trials